SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: S-3
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea0266812-s3_synergy.htm

Chunk 4 of 26
Word Count: 1497
Character Count: 9766

Document Content:

specific consumer needs as well as lifestyle choices and we seek to deepen our understanding of our customers and boost recognition of our brands through increased engagement. Continue to Develop and Expand Our Current Brands Our plan is to further develop and expand our brands by reaching a broader set of customers through advertising and product expansion. More specifically, we look to develop new products for our brands to satisfy the various customer segment opportunities (i.e., baby boomers, millennials, etc.) and satisfy various consumer needs as they relate to new and improved formulations, expanded and improved product benefits, alternative delivery formats and sizes. As we increase the product line-up behind our brands, we leverage our current retail distribution network by expanding our presence as well as adding incremental distribution with new retail partners. With a broader brand presence, we believe our advertising becomes even more efficient at driving sales velocity.

This is evidenced by our expanded FOCUSfactor product line, including
focus and energy RTD and liquid shots that are marketed to a younger adult audience. In 2023, we successfully launched an RTD pilot program
in the United States through a major retailer. Additionally, in the second quarter of 2024, we launched three core FOCUSfactor focus
and energy RTD products in Canada. In 2025, we plan to introduce an additional FOCUSfactor supplement for Taiwan, RTDs for the UK and
focus and energy coffee for the United States. We also introduced new graphics for the FOCUSfactor line that provide a more impactful
design, in the third quarter of 2024. In the first quarter of 2026, we introduced new complementary products to the Flat Tummy line-up,
including new protein shakes, GLP-1 support products and pre-workout powders. Additionally, we plan to employ this strategy of expanding
our brands into international markets that include Mexico and Asia, among others.

Marketing and Sales

Our targeted, consumer-driven marketing
strategy has been key to building our brands and driving revenue growth. We manage dedicated marketing strategies for each of our brands
in order to build deep connections with our customers.

FOCUSfactor.    Our marketing strategy for FOCUSfactor is primarily focused on increased
distribution and advertising campaigns that appeal to the demographics of our wellness focused customer base. For the year ended December 31,
2024, FOCUSfactor net revenue decreased 17% year-over-year, to $30.7 million, primarily due to the rebranding and packaging upgrade
we undertook. As our flagship brand, FOCUSfactor accounted for 86% of our net revenue in the nine months ended September 30, 2025, compared
with 87% for the nine months ended September 30, 2024, 88% in the year ended December 31, 2024, compared to 87% for the year ended
December 31, 2023.

Flat Tummy.    We employ a primarily online and social media driven strategy for our
Flat Tummy brand. The brand is focused primarily on women. We employ campaigns to reach our core target segments through a mix of traditional
online advertising as well as influencer-based marketing. For the nine months ended September 30, 2025, Flat Tummy accounted for
14% of our net revenue, compared with 13% in the nine months ended September 30, 2024, 12% of our net revenue in the year ended December 31,
2024, compared to 13% for the year ended December 31, 2023.

Competition

The U.S. nutritional supplements
retail industry is a large and highly fragmented industry with few barriers to entry. We compete against other domestic and international
manufacturers, specialty retailers, mass merchants, multi-level marketing organizations, mail-order and direct-to-consumer companies,
and e-commerce companies. This market is highly sensitive to the introduction of new products, which may rapidly capture a significant
share of the market. Certain of our competitors may have significantly greater financial, technical and marketing resources than we do,
and may be able to adapt to changes in consumer preferences more quickly, devote greater resources to the marketing and sale of their
products, or generate greater brand recognition. In addition, our competitors may be more effective and efficient in introducing new products.

Corporate Information

We were organized as a corporation
under the laws of the State of Nevada on December 29, 2010 under the name “Oro Capital Corporation.” In April 2014,
Synergy Strips Corp., a Delaware corporation, became our wholly-owned subsidiary, and we changed our name from “Oro Capital
Corporation” to “Synergy Strips Corp.” In August 2015, we changed our name to “Synergy CHC Corp.” In
January 2019, our other U.S. subsidiaries, Neuragen Corp., Sneaky Vaunt Corp., The Queen Pegasus Corp. and Breakthrough Products
Inc., merged with and into the Company. Synergy is the sole owner of four subsidiaries: NomadChoice Pty Ltd., Hand MD Corp., Synergy CHC
Inc. and Synergy CHC Mexico, and the results have been consolidated in these statements. Synergy CHC Mexico was incorporated during May
2025 for the purposes of expanding into Mexico.

We completed our initial public
offering on October 24, 2024, and became subject to the information and reporting requirements of the Exchange Act. We file
periodic reports, proxy statements and other information with the SEC.

The address of our principal
executive offices is 865 Spring Street, Westbrook, Maine 04092 and our phone number is (207) 321-2350. Our website is www.synergychc.com.
The information contained in, or that can be accessed through, our website is not incorporated by reference in, and is not part of, this
prospectus.

RISK FACTORS

Investing in our securities
involves significant risks. Before making an investment decision, you should carefully consider the risks and other information we include
or incorporate by reference in this prospectus and any prospectus supplement. In particular, you should consider the risk factors under
the heading “Risk Factors” included in our most recent Annual Report on Form 10-K, as may be revised or supplemented by our
subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, each of which are on file with the SEC and are incorporated
herein by reference, and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the
future. The risks and uncertainties we have described are not the only ones facing our company. Additional risks and uncertainties not
currently known to us may also affect our business operations. Additional risk factors may be included in a prospectus supplement relating
to a particular offering of securities. Our business, financial condition or results of operations could be materially adversely affected
by any of these risks. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your
investment. This prospectus is qualified in its entirety by these risk factors.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus, including
the documents that we incorporate by reference, contains forward-looking statements as that term is defined in the federal securities
laws. The events described in forward-looking statements contained in this prospectus, including the documents that we incorporate by
reference, may not occur. Generally, these statements relate to our business plans or strategies, projected or anticipated benefits or
other consequences of our plans or strategies, financing plans, projected or anticipated benefits from acquisitions that we may make,
or projections involving anticipated revenues, earnings or other aspects of our operating results or financial position, and the outcome
of any contingencies. Any such forward-looking statements are based on current expectations, estimates and projections of management.
We intend for these forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements. Words such
as “may,” “expect,” “believe,” “anticipate,” “project,” “plan,”
“intend,” “estimate,” and “continue,” and their opposites and similar expressions are intended to
identify forward-looking statements. We caution you that these statements are not guarantees of future performance or events and are
subject to a number of uncertainties, risks and other influences, many of which are beyond our control that may influence the accuracy
of the statements and the projections upon which the statements are based. Factors that may affect our results include, but are not limited
to, the risks and uncertainties discussed in any prospectus supplement to this prospectus in our Annual Report on Form 10-K for the fiscal
year ended December 31, 2024 or in other reports we file with the SEC, among other things:

●	our ability to compete in our industry, including against competitors
that have significantly greater financial, technical and marketing resources than we do;

●	our ability to respond to customer preferences and successfully
develop new and innovative products in a timely manner and effectively manage the introduction of new or enhanced products;

●	risks related to a loss of, or material cancellation, reduction,
or delay in purchases by, one or more of our largest customers;

●	our outside suppliers and manufacturers failing to supply products
in sufficient quantities and in a timely fashion;

●	our ability to execute on our strategic initiatives (including
acquisitions);

●	our ability to maintain the reputation of our brands;

●	the risks related to consumers’ perception of the safety
and quality of our products as well as similar products distributed by other companies in our industry;